Abstract
Aim: Our aim is to elucidate whether galantamine, known as an acetylcholinesterase inhibitor, reduces brain damage induced by hypoxia‐ischemia (HI).Study design: 7‐day‐old Wistar rats were used. Rats were subjected to left carotid artery ligation followed by 2 h of hypoxia (8% oxygen). We injected galantamine intraperitoneally just before hypoxia (5.0 mg/kg, n = 14; 2.5 mg/kg, n = 9; 1.0 mg/kg, n = 11) and after hypoxia (5.0 mg/kg, n = 7) to determine its neuroprotective effect. An equivalent volume of saline was administered as a control before (n = 31) and after hypoxic load (n = 7). We also examined the production of IL‐1β in the ligated hemisphere side after injection of galantamine (prior hypoxia; 5.0 mg/kg, n = 7) or saline (n = 8). Brains were analyzed 7 days after HI.Results: Two of the 5.0 mg/kg galantamine pre‐treated rats and a post‐treated rat died during experiments. The remaining survived and 5.0 mg/kg galantamine pre‐treated rats showed a marked reduction of brain damage (p < 0.01) compared with the control. The other galantamine groups had severe brain damage similar to controls. Microglial accumulation was significantly reduced in rats pre‐treated with 5.0 mg/kg of galantamine compared to control rats on both the hippocampus (p = 0.02) and cortex (p < 0.01). In contrast, the other galantamine groups showed a lower suppressive effect on microglial accumulation compared to the control. Galantamine significantly reduced IL‐1β productions when compared to the control (p < 0.01).Conclusion: Pre‐treatment of galantamine reduced brain damage with a suppressive effect on microglial accumulation and IL‐1β production in a newborn rat model of HI.
Funding Information
  • Japan Society for the Promotion of Science (#24592476, #24592477)
  • Ministry of Education, Culture, Sports, Science and Technology (#79‐258)

This publication has 29 references indexed in Scilit: